explore -WSS

explore

author：knowledge 2025-08-27 16:48:00 - browse：3568

Miniatures sit and stand on coin stacks that lined up from the tallest to the shortest — hospitals coverage from STAT — Adobe

Americans, especially Medicare beneficiaries, are getting more medical care these days. Demand from aging Baby Boomers is keeping people in doctor’s offices, and health care providers are continuing to build capacity post-Covid.

Those trends — the same ones that tanked health insurance stocks a few weeks ago — made a strong mark on nonprofit health systems’ first quarter financial reports. STAT took a look at 20 large nonprofit health systems and found that all but four reported higher operating and net margins in the first three months of 2024 compared with the same period in 2023. Hospitals are seeing more patients and cutting down on the expensive contract labor they relied on during the Covid-19 pandemic. And they’re seeing strong investment gains on the non-operating side.

Volumes are just part of hospitals’ broader strategy to improve margins over the past few years, said Rick Kes, a health care partner with tax and consulting firm RSM. That includes things like fighting insurance denials and getting better deals from vendors for key supplies like drugs and medical devices.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Can gargling with Listerine treat gonorrhea of the mouth?

WSS

CRISPR base editing slashes cholesterol levels in monkeys

PBM executives asked to testify by House panel

AI for drug discovery: Experts on separating hype from reality

The Karikó problem: Lessons for funding basic research

Readout Newsletter: Biotech news, Wall Street disappointment, Lilly's drug delays

Welsh Carson private equity firm escapes from FTC antitrust case

hotspot

explore

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Wikipedia

DIEP, the 'gold standard' of breast reconstruction, is under threat

Deliver public health messages at the right time

As demand for Covid shots wanes, Moderna seeks its next success

AltruBio raises $225 million to develop ulcerative colitis drug

New air purifier tech could be key to improving indoor air quality

The creative science of coining drug names

Dobbs anniversary: the lost opportunity of abortion as health care

Some top drug companies are starting to take action on climate

How to save PrEP access — and even expand it

Readout Newsletter: PTC, Dyne, Rapport, Cytokinetics news

focus

The biotech scorecard for Q4: 16 stock

Crowdfunding for medical bills sidesteps core problem, author says

HHS's proposed rule does nothing to address the climate crisis

What we owe ALS patients — and why one company fell short

HHS's proposed rule does nothing to address the climate crisis

Chemotherapy before breast cancer surgery might fuel metastasis

focus

entertainment

focus

entertainment